Bigfoot Biomedical lands $45M as it readies first diabetes product
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
Bigfoot brings in $55M Series B to propel integrated diabetes platform
The California startup is attempting to create a closed-loop and integrated diabetes platform that attracted Abbott, whic has been a partner since July to invest.
The Mechanics of a More Connected Healthcare Ecosystem [Video]
Arbiter’s Anjali Jameson on hospital and payer alignment.
Breakout Labs backs antibacterials, genomics and biosensor tattoos
From California to Boston to NYC, four more life science startups have been accepted into the Thiel Foundation's Breakout Labs, a philanthropic incubator for seed-stage companies.